MedBright AI Investments Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	no data
Board average tenure	2yrs

Recent management updates

Recent updates

CEO

MedBright AI Investments has no CEO, or we have no data on them.

Board Members

Name	Position	Tenure	Compensation	Ownership
Christopher Cherry	Independent Director	3.2yrs	CA$10.00k	0.045% CA$ 1.7k
William Panenka	Chairman of Scientific Advisory Board	7.8yrs	no data	no data
John Simon	Member of Scientific Advisory Board	7.8yrs	no data	no data
Alnoor Nathoo	Director	less than a year	no data	no data
Jaime Gerber	Independent Chairman of the Board	less than a year	no data	3.4% CA$ 131.3k
Konita Wilks	Independent Director	less than a year	no data	no data

2.0yrs

Average Tenure

Experienced Board: MBAI's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.

MedBright AI Investments Management

Management criteria checks 0/4

Key information

Recent management updates

MedBright AI Investments Inc. Appoints Christopher Heath as Chief Executive Officer

MedBright AI Investments Inc. Announces CEO Changes

MedBright AI Investments Inc. Announces Board Appointments

Vinergy Capital Inc., Annual General Meeting, Dec 01, 2023

Vinergy Capital Inc. Appoints Michael Dalsin as Chairman of Investment Committee

Vinergy Capital Inc. Announces Retirement of Arif Merali from the Board of Director

Recent updates

MedBright AI Investments Inc. Appoints Christopher Heath as Chief Executive Officer

New major risk - Financial position

MedBright AI Investments Inc. Announces CEO Changes

MedBright AI Investments Inc. (CNSX:MBAI) executed a letter of intent to acquire MedBright AI Investments Inc. (TSX:NUMI) for CAD 16.2 million in a reverse merger transaction.

New major risk - Market cap size

MedBright AI Investments Inc. announced that it has received CAD 1.398977 million in funding

MedBright AI Investments Inc. announced that it expects to receive CAD 2.798977 million in funding

Medbright AI’s Medmatrix to Expand Its AI Offerings for Cosmetic Marketing & Clinical Trial Analytics

MedBright AI Investments Inc. Announces Board Appointments

MedBright AI Investments Inc. Unveils New Investment Presentation Announces Medmatrix, the AI-Driven Data Analytics and Improvement Platform

Vinergy Capital Inc., Annual General Meeting, Dec 01, 2023

Vinergy Capital Inc. announced that it has received CAD 1.5 million in funding

Vinergy Capital Inc. announced that it expects to receive CAD 1.5 million in funding

Vinergy Capital Inc. Appoints Michael Dalsin as Chairman of Investment Committee

Vinergy Capital Inc. Announces Retirement of Arif Merali from the Board of Director

New major risk - Negative shareholders equity

New major risk - Shareholder dilution

Vinergy Capital Inc. announced that it expects to receive CAD 0.85 million in funding

Vinergy Capital Inc. announced that it expects to receive CAD 0.975 million in funding

Vinergy Announces Resignation of Scott Jackson, Director and Chief Technology Officer

Less than half of directors are independent

Vinergy Capital Inc., Annual General Meeting, Dec 22, 2022

Vinergy Capital Inc. Appoints Scott Jackson as Director and Chief Operating Officer

Vinergy Capital Inc. announced that it has received CAD 1.54585 million in funding

Vinergy Capital Inc. announced that it expects to receive CAD 1.5 million in funding

Vinergy Cannabis Capital Inc. Appoints Dr. Peter White to Its Investment Committee Advisory

Vinergy Cannabis Capital Inc. Appoints Mr. Albert Szmigielski as Advisor to its Investment Committee

Vinergy Cannabis Capital Inc., Annual General Meeting, Dec 29, 2020

Vinergy Cannabis Capital Inc. announced that it expects to receive CAD 0.3 million in funding

CEO

Board Members

Average Tenure